Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA032672-04
Application #
4691379
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Wikstrand, C J; Hale, L P; Batra, S K et al. (1995) Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res 55:3140-8
Fredman, P (1994) Gangliosides associated with primary brain tumors and their expression in cell lines established from these tumors. Prog Brain Res 101:225-40
Schold Jr, S C; Zalutsky, M R; Coleman, R E et al. (1993) Distribution and dosimetry of I-123-labeled monoclonal antibody 81C6 in patients with anaplastic glioma. Invest Radiol 28:488-96
Meisenberg, B R; Ross, M; Vredenburgh, J J et al. (1993) Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. J Natl Cancer Inst 85:1080-5
Slingluff Jr, C L; Vollmer, R T; Seigler, H F (1993) Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery 113:330-9
Wikstrand, C J; Fredman, P; Svennerholm, L et al. (1992) Monoclonal antibodies to malignant human gliomas. Mol Chem Neuropathol 17:137-46
Slingluff Jr, C L; Seigler, H F (1992) Anorectal melanoma: clinical characteristics and the role of abdominoperineal resection. Ann Plast Surg 28:85-8
Slingluff Jr, C L; Seigler, H F (1992) Malignant melanoma and pregnancy. Ann Plast Surg 28:95-9
Darrow, T L; Wahab, Z; Quinn-Allen, M A et al. (1992) Human melanoma-mediated inhibition of autologous CD4+ helper tumor-infiltrating lymphocyte growth in vitro. Cancer 69:1843-9
Selvan, R S; Metzgar, R S; Petrow, V (1992) Growth modulatory effects of some 6-methylenic steroids on human and hamster pancreatic adenocarcinoma cells in vitro. Drug Des Discov 9:119-33

Showing the most recent 10 out of 98 publications